Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease

BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver diseases in recent years. The aim of this study was to evaluate the effects of sitagliptin with and without a synbiotic supplement in the treatment of patients with NAFLD. METHODS: In total, 138 NAF...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayari, Saba, Neishaboori, Hassan, Jameshorani, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166102/
https://www.ncbi.nlm.nih.gov/pubmed/29890569
http://dx.doi.org/10.3350/cmh.2018.0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166102/
https://www.ncbi.nlm.nih.gov/pubmed/29890569
http://dx.doi.org/10.3350/cmh.2018.0006

Ejemplares similares